---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-093554"
form_type: "8-K"
ticker: null
cik: "0001772028"
company_name: "Scopus BioPharma Inc."
filed_at: "2023-08-18T23:59:59+00:00"
generated_at: "2026-06-11T06:59:43.597766+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "medium"
source: SEC EDGAR
---

# Scopus BioPharma increases authorized common shares via charter amendment

## Summary
- Stockholders approved increase in authorized shares of common stock on August 10, 2023.
- Certificate of Amendment filed with Delaware Secretary of State, effective August 14, 2023.
- Amendment attached as Exhibit 3.1 to the 8-K.

## SEC filing metadata
- accession: 0001104659-23-093554
- form_type: 8-K
- cik: 0001772028
- company_name: Scopus BioPharma Inc.
- filed_at: 2023-08-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: medium
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1772028/000110465923093554/0001104659-23-093554-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1772028/000110465923093554/tm2324079d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-093554
- JSON: https://secwatch.observer/filing/0001104659-23-093554.json
- Plain text: https://secwatch.observer/filing/0001104659-23-093554.txt

## Key facts
- Governance Changes
  Scopus BioPharma Inc.: Increased number of authorized shares of common stock (effective 2023-08-14).
  - Change: charter amendment
  - Effective: 2023-08-14
  source text: The Company filed a Certificate of Amendment (the “Amendment”) with the Secretary of State of Delaware to effectuate the Authorized Share Increase, which became effective in Delaware on August 14, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1772028/000110465923093554/0001104659-23-093554-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.